DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Markowitz JN, Fancher KM.
Cabozantinib: A Multitargeted Oral Tyrosine Kinase Inhibitor.
Pharmacotherapy 2018;
38: 357-369
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.